1 - 25 of 83 results for author:"Roos D." in Literature citations
Results Customize
› Repeat search in UniProtKB (31,109)
| The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Hall A.O., Beiting D.P., Tato C., John B., Oldenhove G., Lombana C.G., Pritchard G.H., Silver J.S., Bouladoux N., Stumhofer J.S. et al. Immunity 37:511-523(2012) · Mapped (37) |
| Comparative genomics of the apicomplexan parasites Toxoplasma gondii and Neospora caninum: Coccidia differing in host range and transmission strategy. Reid A.J., Vermont S.J., Cotton J.A., Harris D., Hill-Cawthorne G.A., Konen-Waisman S., Latham S.M., Mourier T., Norton R., Quail M.A. et al. PLoS Pathog. 8:e1002567-e1002567(2012) · UniProtKB (7,111) |
| Rare duplication or deletion of exons 6, 7 and 8 in CYBB leading to X-linked chronic granulomatous disease in two patients from different families. Stasia M.J., van Leeuwen K., de Boer M., Martel C., Mollin M., Thuret I., Michel G., Hanson C., Augustine N.H., Coutton C. et al. J. Clin. Immunol. 32:653-662(2012) · Mapped (4) |
| Targeted disruption of Toxoplasma gondii serine protease inhibitor 1 increases bradyzoite cyst formation in vitro and parasite tissue burden in mice. Pszenny V., Davis P.H., Zhou X.W., Hunter C.A., Carruthers V.B., Roos D.S. Infect. Immun. 80:1156-1165(2012) · UniProtKB (3) |
| Hematologically important mutations: leukocyte adhesion deficiency (first update). van de Vijver E., Maddalena A., Sanal O., Holland S.M., Uzel G., Madkaikar M., de Boer M., van Leeuwen K., Koker M.Y., Parvaneh N. et al. Blood Cells Mol. Dis. 48:53-61(2012) · Mapped (12) |
| Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties. Wolach B., Broides A., Zeeli T., Gavrieli R., de Boer M., van Leeuwen K., Levy J., Roos D. J. Clin. Immunol. 31:560-566(2011) · Mapped (4) |
| Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation. Jaffe E.K., Shanmugam D., Gardberg A., Dieterich S., Sankaran B., Stewart L.J., Myler P.J., Roos D.S. J. Biol. Chem. 286:15298-15307(2011) · UniProtKB (1) |
| CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Marcos V., Zhou Z., Yildirim A.O., Bohla A., Hector A., Vitkov L., Wiedenbauer E.M., Krautgartner W.D., Stoiber W., Belohradsky B.H. et al. Nat. Med. 16:1018-1023(2010) · Mapped (9) |
| Hematologically important mutations: X-linked chronic granulomatous disease (third update). Roos D., Kuhns D.B., Maddalena A., Roesler J., Lopez J.A., Ariga T., Avcin T., de Boer M., Bustamante J., Condino-Neto A. et al. Blood Cells Mol. Dis. 45:246-265(2010) · Mapped (4) |
| Molecular basis of autosomal recessive chronic granulomatous disease in iran. Teimourian S., de Boer M., Roos D. J. Clin. Immunol. 30:587-592(2010) · Mapped (8) |
| Human NLRP3 inflammasome activation is Nox1-4 independent. van Bruggen R., Koker M.Y., Jansen M., van Houdt M., Roos D., Kuijpers T.W., van den Berg T.K. Blood 115:5398-5400(2010) · Mapped (10) |
| Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Roos D., Kuhns D.B., Maddalena A., Bustamante J., Kannengiesser C., de Boer M., van Leeuwen K., Koker M.Y., Wolach B., Roesler J. et al. Blood Cells Mol. Dis. 44:291-299(2010) · UniProtKB (1) · Mapped (13) |
| Alu-repeat-induced deletions within the NCF2 gene causing p67-phox-deficient chronic granulomatous disease (CGD). Gentsch M., Kaczmarczyk A., van Leeuwen K., de Boer M., Kaus-Drobek M., Dagher M.C., Kaiser P., Arkwright P.D., Gahr M., Rosen-Wolff A. et al. Hum. Mutat. 31:151-158(2010) · Mapped (5) |
| Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. van Bruggen R., Drewniak A., Jansen M., van Houdt M., Roos D., Chapel H., Verhoeven A.J., Kuijpers T.W. Mol. Immunol. 47:575-581(2009) · Mapped (3) |
| Inherited glutathione reductase deficiency and Plasmodium falciparum malaria--a case study. Gallo V., Schwarzer E., Rahlfs S., Schirmer R.H., van Zwieten R., Roos D., Arese P., Becker K. PLoS ONE 4:e7303-e7303(2009) · Mapped (2) |
| Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Weyemi U., Caillou B., Talbot M., Ameziane-El-Hassani R., Lacroix L., Lagent-Chevallier O., Al Ghuzlan A., Roos D., Bidart J.M., Virion A. et al. Endocr. Relat. Cancer 17:27-37(2010) · Mapped (6) |
| Mannose-binding lectin (MBL) substitution: recovery of opsonic function in vivo lags behind MBL serum levels. Brouwer N., Frakking F.N., van de Wetering M.D., van Houdt M., Hart M., Budde I.K., Strengers P.F., Laursen I., Houen G., Roos D. et al. J. Immunol. 183:3496-3504(2009) · Mapped (3) |
| Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations. Koker M.Y., Sanal O., van Leeuwen K., de Boer M., Metin A., Patiroglu T., Ozgur T.T., Tezcan I., Roos D. Eur. J. Clin. Invest. 39:942-951(2009) · UniProtKB (1) |
| A novel mutation in NCF1 in an adult CGD patient with a liver abscess as first presentation. van de Vosse E., van Wengen A., van Geelen J.A., de Boer M., Roos D., van Dissel J.T. J. Hum. Genet. 54:313-316(2009) · Mapped (2) |
| Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B. Breunis W.B., van Mirre E., Geissler J., Laddach N., Wolbink G., van der Schoot E., de Haas M., de Boer M., Roos D., Kuijpers T.W. Hum. Mutat. 30:E640-50(2009) · Mapped (15) |
| Six different CYBA mutations including three novel mutations in ten families from Turkey, resulting in autosomal recessive chronic granulomatous disease. Koker M.Y., van Leeuwen K., de Boer M., Celmeli F., Metin A., Ozgur T.T., Tezcan I., Sanal O., Roos D. Eur. J. Clin. Invest. 39:311-319(2009) · Mapped (2) |
| LAD-1/variant syndrome is caused by mutations in FERMT3. Kuijpers T.W., van de Vijver E., Weterman M.A.J., de Boer M., Tool A.T.J., van den Berg T.K., Moser M., Jakobs M.E., Seeger K., Sanal O. et al. Blood 113:4740-4746(2009) · UniProtKB (2) |
| Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. Hartl D., Krauss-Etschmann S., Koller B., Hordijk P.L., Kuijpers T.W., Hoffmann F., Hector A., Eber E., Marcos V., Bittmann I. et al. J. Immunol. 181:8053-8067(2008) · Mapped (39) |
| TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. Koller B., Kappler M., Latzin P., Gaggar A., Schreiner M., Takyar S., Kormann M., Kabesch M., Roos D., Griese M. et al. J. Immunol. 181:2753-2763(2008) · Mapped (18) |
| Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. Pepper M., Dzierszinski F., Wilson E., Tait E., Fang Q., Yarovinsky F., Laufer T.M., Roos D., Hunter C.A. J. Immunol. 180:6229-6236(2008) · Mapped (2) |